# Symptom Assessment for Patients With Gastro-esophageal Reflux Disease Receiving Helicobacter Pylori Eradication

> **NCT02934152** · PHASE4 · UNKNOWN · sponsor: **National Taiwan University Hospital** · enrollment: 400 (estimated)

## Conditions studied

- Gastroesophageal Reflux Disease

## Interventions

- **DRUG:** H pylori eradication
- **OTHER:** H pylori eradication timing

## Key facts

- **NCT ID:** NCT02934152
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-10
- **Primary completion:** 2019-09
- **Final completion:** 2019-09
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2016-10-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02934152

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02934152, "Symptom Assessment for Patients With Gastro-esophageal Reflux Disease Receiving Helicobacter Pylori Eradication". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02934152. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*